SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Provectus Pharmaceuticals Inc.
PVCT 0.0600-6.3%Nov 10 3:45 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
Recommended by:
Jack Russell
Khris Smith
To: tcd who wrote (12581)1/3/2014 9:24:48 AM
From: boomertree22 Recommendations  Read Replies (2) of 13111
 
tcd, the ONCS post you referenced was cut and pasted directly from the San Diego Union Tribune, and that source was cited in my post. I posted it as I thought it may be of interest to this board as ONCS, like PV-10, is a melanoma cancer treatment in FDA trials. It was not represented as a comprehensive analysis of the ONCS FDA trial results, but was merely a summary of the results from a local newspaper.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News